- The AHA guidelines for the treatment of cardiac arrest are based on high-quality clinical trials, which depend on the selection of a meaningful primary outcome.
- This consensus statement is intended for researchers, clinicians, reviewers, and regulators in the selection of the most appropriate primary outcome for clinical trials of cardiac arrest therapies.
- This paper focuses on (1) when after cardiac arrest the measurement time point should occur; (2) what cardiovascular, neurological, and other physiology should be assessed; and (3) the costs associated with various end points.
Read the full article in Circulation
Circulation. 2011, published online before print October 3, 2011, 10.1161/CIR.0b013e3182340239